Background Color:
 
Background Pattern:
Reset
Saturday, August 29, 2015
Menu

About Us The Team News

CLINICAL HIV RESEARCH UNIT (CHRU)

South Africa is at the epicentre of the HIV and tuberculosis (TB) epidemics. In a country of 51.7 million people, adult HIV prevalence is 17.9%, with nearly 6 million people living with HIV, the largest number in any country worldwide. The TB epidemic also continues unabated, with an estimated 948 new cases of TB annually per 100,000 population. The Clinical HIV Research Unit (CHRU) which was founded in August 1997, is today an established, highly successful and internationally recognised multi-disciplinary research group. CHRU’s activities comprise a wide variety of academic research and technical assistance pursuits ranging from Phase I to IV clinical Trials, to implementation sciences, and epidemiology and health economics. The Unit, based in Johannesburg, continues to grow from strength to strength, increasing the grant funded support, publication output and post-graduate research output.

CHRU is a division of the Wits Health Consortium, www.witshealth.co.za, which is a wholly owned company of the University of the Witwatersrand (www.wits.ac.za) Johannesburg, South Africa, under its faculty of Health Services. WHC is a not-for-profit organisation.